Identification of a neuronal transcription factor network involved in medulloblastoma development

  1. Lookup NU author(s)
  2. Dr Maria Lastowska
  3. Hani Al-Afghani
  4. Haya AL-Balool
  5. Harsh SHETH
  6. Dr Jonathan Coxhead
  7. Dr Christopher Redfern
  8. Dr Heiko Peters
  9. Professor Alastair Burt
  10. Dr Mauro Santibanez Koref
  11. Dr Christopher Bacon
  12. Professor Steven Clifford
  13. Dr Michael Jackson
Author(s)Ɓastowska M, Al-Afghani H, Al-Balool HH, Sheth H, Mercer E, Coxhead JM, Redfern CPF, Peters H, Burt AD, Santibanez-Koref M, Bacon CM, Chesler L, Rust AG, Adams DJ, Williamson D, Clifford SC, Jackson MS
Publication type Article
JournalActa Neuropathologica Communications
Year2013
Volume1
Issue
Pages
ISSN (electronic)2051-5960
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Background: Medulloblastomas, the most frequent malignant brain tumours affecting children, comprise at least 4 distinct clinicogenetic subgroups. Aberrant sonic hedgehog (SHH) signalling is observed in approximately 25% of tumours and defines one subgroup. Although alterations in SHH pathway genes (e.g. PTCH1, SUFU) are observed in many of these tumours, high throughput genomic analyses have identified few other recurring mutations. Here, we have mutagenised the Ptch+/- murine tumour model using the Sleeping Beauty transposon system to identify additional genes and pathways involved in SHH subgroup medulloblastoma development. Results: Mutagenesis significantly increased medulloblastoma frequency and identified 17 candidate cancer genes, including orthologs of genes somatically mutated (PTEN, CREBBP) or associated with poor outcome (PTEN, MYT1L) in the human disease. Strikingly, these candidate genes were enriched for transcription factors (p=2x10-5), the majority of which (6/7; Crebbp, Myt1L, Nfia, Nfib, Tead1 and Tgif2) were linked within a single regulatory network enriched for genes associated with a differentiated neuronal phenotype. Furthermore, activity of this network varied significantly between the human subgroups, was associated with metastatic disease, and predicted poor survival specifically within the SHH subgroup of tumours. Igf2, previously implicated in medulloblastoma, was the most differentially expressed gene in murine tumours with network perturbation, and network activity in both mouse and human tumours was characterised by enrichment for multiple gene-sets indicating increased cell proliferation, IGF signalling, MYC target upregulation, and decreased neuronal differentiation. Conclusions: Collectively, our data support a model of medulloblastoma development in SB-mutagenised Ptch+/- mice which involves disruption of a novel transcription factor network leading to Igf2 upregulation, proliferation of GNPs, and tumour formation. Moreover, our results identify rational therapeutic targets for SHH subgroup tumours, alongside prognostic biomarkers for the identification of poor-risk SHH patients.
PublisherBioMed Central Ltd.
URLhttp://dx.doi.org/10.1186/2051-5960-1-35
DOI10.1186/2051-5960-1-35
Actions    Link to this publication

Altmetrics provided by Altmetric

Share